menu
    • menu

    Company profile for EnteraBio Ltd

    NEW Drugs in Dev: 5
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics.Entera Bio is currently conducting clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics while enhancing their absorption in the GI tract.Entera Bio's technology addresses the two major problems of oral drug delivery of large molecule APIs (active pharmaceu...
    Entera Bio is a product-focused biotechnology company specializing in the oral delivery of large molecules and biologics.Entera Bio is currently conducting clinical trials on its proprietary technology which allows oral delivery of large molecules and biologics while enhancing their absorption in the GI tract.Entera Bio's technology addresses the two major problems of oral drug delivery of large molecule APIs (active pharmaceutical ingredients). Most large molecules cannot be administered orally as they are not readily absorbed by the gastrointestinal tract.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    EnteraBio LtdIsrael Flag
    Country
    Country
    Israel
    Address
    Address
    Kiryat Hadassah Minrav Building, 5th Floor Po Box 12117 Jerusalem 9122002 Isra...
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.enterabio.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    PEGS Boston Summit

    PEGS Boston Summit

    Not Confirmed

    envelop Contact Supplier

    PEGS Boston Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Entera Reports Q1 2026 Results and Oral Peptide Program Updates
    Entera Reports Q1 2026 Results and Oral Peptide Program Updates

    08 May 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/05/08/3291323/0/en/entera-announces-first-quarter-2026-financial-results-and-updates-across-its-oral-peptide-programs.html

    GLOBENEWSWIRE
    08 May 2026
    Share Share
    Entera Bio Hosts KOL Webinar on Osteoporosis & EB613
    Entera Bio Hosts KOL Webinar on Osteoporosis & EB613

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273411/0/en/Entera-Bio-to-Host-Key-Opinion-Leader-Webinar-Highlighting-the-Osteoporosis-Treatment-Landscape-and-the-Opportunity-for-EB613.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Entera Bio Prices $10M Direct Investment by BVF Partners
    Entera Bio Prices $10M Direct Investment by BVF Partners

    02 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/02/3267368/0/en/Entera-Bio-Announces-Pricing-of-10-0-Million-Direct-Investment-by-BVF-Partners-with-Potential-for-up-to-24-5-Million-in-Total-Proceeds.html

    GLOBENEWSWIRE
    02 Apr 2026
    Share Share
    Entera Bio Unveils 2025 Financials, Business Updates
    Entera Bio Unveils 2025 Financials, Business Updates

    27 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/27/3264088/0/en/Entera-Bio-Announces-Full-Year-2025-Financial-Results-and-Provides-Business-Updates.html

    GLOBENEWSWIRE
    27 Mar 2026
    Share Share
    Entera Bio Submits Phase 3 Protocol For EB613 In Osteoporosis
    Entera Bio Submits Phase 3 Protocol For EB613 In Osteoporosis

    04 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/04/3249357/0/en/Entera-Bio-Submits-Streamlined-Phase-3-Protocol-to-Initiate-Registrational-Program-for-EB613-in-Postmenopausal-Women-with-Osteoporosis.html

    GLOBENEWSWIRE
    04 Mar 2026
    Share Share
    Entera Bio Board Members Make Open Market Stock Purchases
    Entera Bio Board Members Make Open Market Stock Purchases

    11 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/11/3236313/0/en/Entera-Bio-Announces-Open-Market-Purchases-of-Company-Stock-by-Board-Members.html

    GLOBENEWSWIRE
    11 Feb 2026
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search